It has been suggested that the p14ARF-MDM2-p53 pathway is one of the major pathways in the molecular genetic pathogenesis of gliomas, in which p14ARF and MDM2 proteins are involved in glioma development by regulating the ubiquitination-mediated degradation of p53. Here, CDKN2A is linked to central nervous system cancer.